ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665078 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665078; 2) Community: the network communities that were significantly associated with the response to NSC 665078; 3) Molecule: the relationships between components within communities and NSC 665078; 4) MDR: the compounds that were significantly associated with the NSC 665078.

NSC Compound Enrichment Correlation
NSC 691782 Null 0.00454081715455577 0.26079387
NSC 749161 Null 0.00577660600506179 0.13319068
NSC 295500 Camptothecin Derivative 0.00628187335688605 0.012090832
NSC 106557 5.alpha.,25D-Spirostan-3.beta.-ol glycoside 0.00701295499506013 0.040158606
NSC 624523 Null 0.00701295499506013 0.10032902
NSC 664890 Null 0.00701295499506013 0.25897455
NSC 715135 Null 0.0070129549950602 0.12674992
NSC 667088 Null 0.00701295499506023 -0.020095351
NSC 676345 Pyrimidine-2,4-diamine, 6-chloro-N(4)- [[1-(hydroxymethyl)-3-(2-phenylethyl)cyclobutyl]methyl]- 0.00701295499506023 0.0073127883
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.00701295499506023 0.15505777
Total:27  Current:3    [First] [Prev] [Next] [Last]